MYCOPHENOLATE APPROVAL PROVIDES NEW OPTION FOR ORGAN-REJECTION PREVENTION

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1995年 / 52卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2078 / 2078
页数：1
相关论文
共 50 条
  • [31] CellCept(R) (mycophenolate mofetil): A new immunosuppressant for organ transplantation
    Sollinger, HW
    JOURNAL OF NEPHROLOGY, 1996, 9 (02) : 47 - 48
  • [32] Rapamune receives FDA marketing approval for prevention of acute rejection following renal transplantation
    不详
    DIALYSIS & TRANSPLANTATION, 1999, 28 (11) : 623 - 623
  • [33] The Spanish Model of Family Interviewing on Organ Donation: An Option for Germany to Decrease Rejection Rates?
    Poepplein, A. A.
    TRANSPLANTATION, 2012, 94 (10) : 92 - 92
  • [34] How Down syndrome provides a new option against diabetes
    Rachdi, Latif
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (1-2): : 36 - 38
  • [35] Next-generation calcineurin inhibitors in development for the prevention of organ rejection
    Gheith, Osama
    Al-Otaibi, Torki
    Mansour, Hany
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2014, 6 : 23 - 30
  • [36] Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
    Changelian, PS
    Flanagan, ME
    Ball, DJ
    Kent, CR
    Magnuson, KS
    Martin, WH
    Rizzuti, BJ
    Sawyer, PS
    Perry, BD
    Brissette, WH
    McCurdy, SP
    Kudlacz, EM
    Conklyn, MJ
    Elliott, EA
    Koslov, ER
    Fisher, MB
    Strelevitz, TJ
    Yoon, K
    Whipple, DA
    Sun, JM
    Munchhof, MJ
    Doty, JL
    Casavant, JM
    Blumenkopf, TA
    Hines, M
    Brown, MF
    Lillie, BM
    Subramanyam, C
    Shang-Poa, C
    Milici, AJ
    Beckius, GE
    Moyer, JD
    Su, CY
    Woodworth, TG
    Gaweco, AS
    Beals, CR
    Littman, BH
    Fisher, DA
    Smith, JF
    Zagouras, P
    Magna, HA
    Saltarelli, MJ
    Johnson, KS
    Nelms, LF
    Des Etages, SG
    Hayes, LS
    Kawabata, TT
    Finco-Kent, D
    Baker, DL
    Larson, M
    SCIENCE, 2003, 302 (5646) : 875 - 878
  • [37] Prevention of organ rejection in renal and liver transplantation with extended release tacrolimus
    Reschen, Michael E.
    O'Callaghan, Christopher A.
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2014, 6 : 55 - 72
  • [38] Mycophenolate mofetil (MMF) in the prevention of renal allograft rejection (AR): A single center experience.
    Rodriguez, M
    Inchaustegui, L
    Niembro, E
    Rodriguez, P
    Lorenzo, I
    Anaya, F
    Valderrabano, F
    Rengel, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3262 - A3262
  • [39] Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients
    Park, K
    Kim, SI
    Moon, JI
    Kim, YS
    Kim, MS
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3575 - 3575
  • [40] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
    Kreis, H
    Cisterne, JM
    Land, W
    Wramner, L
    Squifflet, JP
    Abramowicz, D
    Campistol, JM
    Morales, JM
    Grinyo, JM
    Mourad, G
    Berthoux, FC
    Brattström, C
    Lebranchu, Y
    Vialtel, P
    TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260
12345